A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout
Clinical trial NCT05007392 · COMPLETED
Trial details
- NCT number
- NCT05007392
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-21
- Primary completion
- 2023-06-14
- Enrollment
- 451
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.